Content

01

Executive Summary

Timeline

Background: Jakafi (ruxolitinib)

Merkel cell carcinoma

Association with Skin Cancer: Merkel Cell and other malignancies

02

Discussion

Summary of supporting evidence

Confounding factors

Strength of available evidence

03

Works Cited

Citations of peer-reviewed articles

04

Next Steps

Phone consultation

Expert Engagement

Areas of interest

Med

Oncology

Medical Malpractice

Subscribe for unlimited access to every document

A subscription to the Research Guide Library, gets you complete access to all our medico-legal research for a fraction of the cost.